Publications

Goldberg, J. S., and J. B. Weinberg. “USE OF POLYMER D-LACTIC ACID (PDLA) OR EQUIVALENTS THEREOF TO INHIBIT GROWTH OF CANCER CELLS AND DIAGNOSE CANCER.” USPTO, December 30, 2019.

Scholars@Duke

Ashton, PM, Thanh, LT, Trieu, PH, Van Anh, D, Trinh, NM, Beardsley, J, Kibengo, F, Chierakul, W, Dance, DAB, Rattanavong, S, Davong, V, Hung, LQ, Chau, NVV, Tung, NLN, Chan, AK, Thwaites, GE, Lalloo, DG, Anscombe, C, Nhat, LTH, Perfect, J, Dougan, G, Baker, S, Harris, S, and Day, JN. "Three phylogenetic groups have driven the recent population expansion of Cryptococcus neoformans(Accepted)." Nature Communications 10, no. 1 (December 1, 2019).

Full Text

Sanyal, Arun, Edgar D. Charles, Brent A. Neuschwander-Tetri, Rohit Loomba, Stephen A. Harrison, Manal F. Abdelmalek, Eric J. Lawitz, et al. “Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial..” Lancet (London, England) 392, no. 10165 (December 2019): 2705–17. https://doi.org/10.1016/s0140-6736(18)31785-9.

PMID
30554783
Full Text

Ashton, P. M., L. T. Thanh, P. H. Trieu, D. Van Anh, N. M. Trinh, J. Beardsley, F. Kibengo, et al. “Three phylogenetic groups have driven the recent population expansion of Cryptococcus neoformans.” Nature Communications 10, no. 1 (December 1, 2019). https://doi.org/10.1038/s41467-019-10092-5.

Full Text

Riedel, R., S. Michels, C. Heydt, J. Siemanowski, C. Kobe, A. Bunck, S. Schäfer, et al. “Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinoma.” Lung Cancer 133 (July 1, 2019): 20–22. https://doi.org/10.1016/j.lungcan.2019.05.006.

Full Text

Emdin, Michele, Alberto Aimo, Aldo Clerico, and James L. Januzzi. “Race/ethnicity and plasma NT-proBNP in black and white individuals: How it matters..” Int J Cardiol 286 (July 1, 2019): 164–65. https://doi.org/10.1016/j.ijcard.2019.03.032.

PMID
30948217
Full Text

Riedel, R, Michels, S, Heydt, C, Siemanowski, J, Kobe, C, Bunck, A, Schäfer, S, Fischer, RN, Scheffler, M, Abdulla, DSY, Nogová, L, Koleczko, S, Merkelbach-Bruse, S, Büttner, R, and Wolf, J. "Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinoma(Accepted)." Lung Cancer 133 (July 1, 2019): 20-22.

Full Text

Riedel, R, Michels, S, Heydt, C, Siemanowski, J, Kobe, C, Bunck, A, Schäfer, S, Fischer, RN, Scheffler, M, Abdulla, DSY, Nogová, L, Koleczko, S, Merkelbach-Bruse, S, Büttner, R, and Wolf, J. "Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinoma(Accepted)." Lung Cancer 133 (July 1, 2019): 20-22.

Full Text

Pages